Anti-VEGFR2/KDR/CD309 Antibody (Olinvacimab)
Catalog No.
F2044
Anti-VEGFR2/KDR/CD309 Antibody (Olinvacimab)
Featured Products
Olinvacimab (TTAC-0001) is a human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binding to KDR with a Kd value of 0.23 nM. Olinvacimab has anti-angiogenic activity. Olinvacimab can be used in the study of recurrent glioblastoma and breast cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
148.16 kDa
Dry ice
2095504-49-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TTAC-0001, TTAC0001, Tanibirumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P35968
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
VEGFR2 / KDR / CD309
Please avoid freeze-thaw cycles.